Palisade Bio (PALI) Shares Outstanding (2010 - 2026)

Palisade Bio (PALI) has reported Shares Outstanding (Entity) for 17 consecutive years, with $209.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 4668.73% year-over-year to $209.7 million; the TTM figure through Mar 2026 stood at $209.7 million (up 4668.73% YoY), while the FY2025 annual figure was $55.7 million, up 3830.18% from the prior year.
• Shares Outstanding (Entity) climbed to $209.7 million in Q1 2026 per PALI's latest filing, from $55.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $209.7 million in Q1 2026 and bottomed at $24313.0 in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $17.0 million across 5 years, with a median of $851302.0 in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 147.75% — and 2026, when it soared 4668.73%.
• Palisade Bio's Shares Outstanding (Entity) stood at $58690.0 in 2022, then surged by 677.03% to $456037.0 in 2023, then soared by 210.6% to $1.4 million in 2024, then jumped by 3830.18% to $55.7 million in 2025, then jumped by 276.62% to $209.7 million in 2026.
• Business Quant data shows PALI's Shares Outstanding (Entity) at $209.7 million in Q1 2026, $55.7 million in Q4 2025, and $7.5 million in Q3 2025.